Baolin L. Qian
Luzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
3,3'-diindolylmethane ameliorates non-alcoholic fatty liver disease by inhibiting the FMO3-TMAO axis in mice.
Journal: Biochemical and biophysical research communications
Published: March 11, 2026
RGS16 Aggravates Hepatic Ischemia-Reperfusion Injury via Hepatocyte-Intrinsic Apoptosis/Inflammation & Neutrophil Recruitment/NETosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 15, 2026
Cancer-Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT-ANGPTL4 Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 27, 2025
Letter to the Editor: The treatment options for de novo perihilar cholangiocarcinoma require more details.
Journal: Hepatology (Baltimore, Md.)
Published: July 11, 2025
Novel Perspectives in Hepatic Ischemia-Reperfusion Injury: The cGAS-STING Pathway.
Journal: Journal of inflammation research
Published: June 25, 2025
Phosphatidylethanol-guided reclassification of steatotic liver disease subgroups improves prognostic stratification: Greater precision is required.
Journal: Journal of hepatology
Published: April 25, 2025
Immune Microenvironment on the Molecular Mechanisms and Therapeutic Targets of MAFLD.
Journal: ImmunoTargets and therapy
Published: April 14, 2025
NNMT/1-MNA protects against hepatic ischemia-reperfusion injury through the AKT/FOXO1/ANGPT2/JNK axis.
Journal: Nature communications
Published: October 24, 2024
Identifying shared hub genes in LIRI and MASLD through bioinformatics analysis and machine learning.
Identifying shared hub genes in LIRI and MASLD through bioinformatics analysis and machine learning.
Journal: Scientific reports
Published: October 19, 2024
Axin formation inhibitor 1 aggravates hepatic ischemia‒reperfusion injury by promoting the ubiquitination and degradation of PPARβ.
Journal: Nature communications
Published: August 27, 2024
GRINA alleviates hepatic ischemia‒reperfusion injury-induced apoptosis and ER-phagy by enhancing HRD1-mediated ATF6 ubiquitination.
Journal: Journal of hepatology
Published: July 23, 2024
Last Updated: 09/26/2026